Gout

      RT @drdavidliew: So what diet to follow with autoimmunity in mind?
      So many, all with different instructions.

      Let’s co

      David Liew drdavidliew

      3 years 4 months ago
      So what diet to follow with autoimmunity in mind? So many, all with different instructions. Let’s concentrate on where they agree: yes to fruits & vegetables no to emulsifiers & processed foods #EULAR2022 @RheumNow https://t.co/I9abweQOyZ
      RT @drdavidliew: Hilarious debate #EULAR2022 between Christian Dejaco and Robert Landewe on whether telemedicine is the

      David Liew drdavidliew

      3 years 4 months ago
      Hilarious debate #EULAR2022 between Christian Dejaco and Robert Landewe on whether telemedicine is the future of rheumatology. In amongst the trash talking, here are some highlights @RheumNow
      RT @ericdeinmd: #EULAR2022 POS0278:
      Proof of concept US study:
      💎CPP crystals do NOT generate posterior shadowing
      💎

      Eric Dein ericdeinmd

      3 years 4 months ago
      #EULAR2022 POS0278: Proof of concept US study: 💎CPP crystals do NOT generate posterior shadowing 💎MSU and hydroxyapatite did have shadowing, proportional to concentration of crystals @Rheumnow @MymaAlbaydaMD @USSONAR_Rh
      acr_session2.jpeg
      EULAR 2022 – Day 2 Report
      3 years 4 months ago
      A full day at EULAR with oral and poster presentations of abstracts in the morning and a plethora of scientific (review) sessions in the afternoon. The latter covering topics like sarcoidosis, Still’s disease, fibromyalgia, back pain, sarcopenia, APS, IgG4 and imaging in vasculitis.
      EULAR 2022 - Day 2 Faculty Recap Panel
      3 years 4 months ago
      RT @RichardPAConway: Dr Puja Khanna. Transdermal sodium bicarbonate for gout flare. WHAT!? It works as well! Double-blin

      Richard Conway RichardPAConway

      3 years 4 months ago
      Dr Puja Khanna. Transdermal sodium bicarbonate for gout flare. WHAT!? It works as well! Double-blind RCT. All got colchicine also. Response rate 95% vs 79%. Resolution in 24 vs 72 hrs. Rescue meds 6% vs 20%. No adverse events! @RheumNow #EULAR2022 OP0170 https://t.co/INd4tMFVlV https://t.co/EyVjFLF72z
      RT @RichardPAConway: Farshad et al. 17% of admissions on long-term allopurinol had it held. Reasons - acute gout flare,

      Richard Conway RichardPAConway

      3 years 4 months ago
      Farshad et al. 17% of admissions on long-term allopurinol had it held. Reasons - acute gout flare, renal impairment, gastrointestinal issues, cytopenia, drug interactions, NPO status, and always discontinued the medication. @RheumNow #EULAR2022 OP0169 https://t.co/ADOomiOrRi https://t.co/nxAAOMWsJB
      RT @RichardPAConway: Botson et al. 152 patient RCT. MTX combo with pegloticase (to decrease antidrug abs). 6-month respo

      Richard Conway RichardPAConway

      3 years 4 months ago
      Botson et al. 152 patient RCT. MTX combo with pegloticase (to decrease antidrug abs). 6-month response (sUA<6 mg/dL) 71% vs 39%. Infusion reactions 3% vs 31%. @RheumNow #EULAR2022 OP0171 https://t.co/N29kYT3xkR https://t.co/Z4dUMD4Tt3
      How well do you know this week's rheumatology news?
      Take the rheumIQ quiz
      Take the RheumIQ Quiz

      Catch up on Conference Podcasts

      ×